Table 2.
Multiple regression analysis with epicardial adipose tissue as the outcome variable.
| Model | Liver stiffness (kPa) | Fibrosis-4 Index | NAFLD Fibrosis Score | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Regression coefficient | SE | p value | Regression coefficient | SE | p value | Regression coefficient | SE | p value | |
| Unadjusted | 8.767 | 4.342 | 0.049 | 53.805 | 27.719 | 0.058 | 25.819 | 10.815 | 0.021 |
| 1 | 8.719 | 4.258 | 0.046 | 47.390 | 27.845 | 0.096 | 25.188 | 10.629 | 0.022 |
| 2 | 9.222 | 4.435 | 0.043 | 59.920 | 28.850 | 0.043 | 25.763 | 10.974 | 0.023 |
| 3 | 8.730 | 4.397 | 0.053 | 54.709 | 28.652 | 0.062 | 27.294 | 11.401 | 0.021 |
| 4 | 7.976 | 4.441 | 0.079 | 53.526 | 27.542 | 0.058 | 23.771 | 11.268 | 0.040 |
| 5 | 6.845 | 4.147 | 0.106 | 41.906 | 26.421 | 0.120 | 18.752 | 10.702 | 0.086 |
| 6 | 8.642 | 4.151 | 0.043 | 49.594 | 26.720 | 0.070 | 21.557 | 10.777 | 0.051 |
| 7 | 8.305 | 4.109 | 0.049 | 45.050 | 26.717 | 0.099 | 23.946 | 10.277 | 0.024 |
| 8 | 8.704 | 4.325 | 0.050 | 53.989 | 27.588 | 0.056 | 24.328 | 11.001 | 0.032 |
| 9 | 8.735 | 4.358 | 0.051 | 51.416 | 28.340 | 0.076 | 25.375 | 11.458 | 0.032 |
| 10 | 8.816 | 4.346 | 0.048 | 77.369 | 27.545 | 0.007 | 27.409 | 10.833 | 0.015 |
| 11 | 9.045 | 4.573 | 0.054 | 53.191 | 28.681 | 0.070 | 25.942 | 11.233 | 0.026 |
| 12 | − 3.754 | 3.820 | 0.334 | 45.719 | 26.709 | 0.098 | 11.258 | 10.786 | 0.305 |
| 13 | 6.068 | 4.642 | 0.201 | 67.333 | 37.009 | 0.079 | 30.679 | 12.711 | 0.022 |
| 14 | 7.361 | 4.247 | 0.090 | 57.001 | 26.269 | 0.035 | 19.652 | 11.203 | 0.086 |
| 15 | 8.575 | 4.249 | 0.050 | 52.207 | 30.636 | 0.096 | 16.009 | 13.117 | 0.229 |
SE standard error. Model 1: adjusted for sex. Model 2: adjusted for carbohydrate intolerance. Model 3: adjusted for diabetes. Model 4: adjusted for hypertension. Model 5: adjusted for dyslipidaemia. Model 6: adjusted for obstructive sleep apnoea syndrome. Model 7: adjusted for hyperuricemia. Model 8: adjusted for statin therapy. Model 9: adjusted for aspirin therapy. Model 10: adjusted for obesity. Model 11: adjusted for smoking. Model 12: adjusted for visceral adipose tissue. Model 13: adjusted for visceral adipose tissue/subcutaneous adipose tissue ratio. Model 14: adjusted for presence of carbohydrate intolerance, hypertension, dyslipidaemia, and obesity (number of factors). Model 15: adjusted for presence of carbohydrate intolerance/diabetes, hypertension, dyslipidaemia, and obesity (number of factors).